Back to results
US 10,117,885 B2Granted
Chewable lipid supplements for treating pain and fibromyalgia
AssigneeAllergy Research Group, LLC
InventorRobert A. Settineri
Life of this patent
Estimating the term…
Abstract
Composition, preferably, in the form of capsules or chewable wafers in quantities suitable for relieving the symptoms of fibromyalgia comprise formulations of phospholipids, specifically identified concentrations of phosphatidylglycerol, phosphatidic acid, phosphatidylethanolamine, phosphatidylcholine, glycolipids and phosphatidylserine along with inulin and other desirable active ingredients are described.
Claims14
A composition comprising:
- a) a base composition comprising a combination of inulin, and phospholipids in therapeutically effective amounts for relieving the symptoms of fibromyalgia, and
- b) a carrier for the base composition comprising xylitol, a flavoring agent, stearic acid and/or vegetable stearate,
- wherein the composition is formulated as a tablet, a capsule, a powder or an edible wafer, said composition effective, when consumed by an individual, for treating fibromyalgia and/or decreasing systemic and abdominal pain due to fibromyalgia, wherein the base composition comprises a combination of phospholipids comprising about 19-29% phosphatidylcholine, 15-25% phosphatidylethanolamine, 3.5-10% phosphatidic acid, 10-18% phosphatidylinositol, 2-10% phosphatidylglycerol, 10-20% glycolipids and phosphatidylserine.
A composition comprising:
- a combination of inulin, and phospholipids in therapeutically effective amounts for relieving the symptoms of fibromyalgia, and
- wherein the composition is formulated as a tablet, a capsule, a powder or an edible wafer, said composition effective, when consumed by an individual, for treating fibromyalgia and/or decreasing systemic and abdominal pain due to fibromyalgia, wherein the composition comprises a combination of phospholipids comprising about 19-29% phosphatidylcholine, 15-25% phosphatidylethanolamine, 3.5-10% phosphatidic acid, 10-18% phosphatidylinositol, 2-10% phosphatidylglycerol, 10-20% glycolipids and phosphatidylserine.
A method for decreasing the symptoms of fibromyalgia and/or systemic and abdominal pain due to fibromyalgia, comprising delivering to an individual:
- a composition comprising:
- a combination of inulin, and phospholipids in therapeutically effective amounts for relieving the symptoms of fibromyalgia, and
- wherein the composition is formulated as a tablet, a capsule, a powder or an edible wafer, said composition effective, when consumed by an individual, for treating fibromyalgia and/or decreasing systemic and abdominal pain due to fibromyalgia, wherein the composition comprises a combination of phospholipids comprising about 19-29% phosphatidylcholine, 15-25% phosphatidylethanolamine, 3.5-10% phosphatidic acid, 10-18% phosphatidylinositol, 2-10% phosphatidylglycerol, 10-20% glycolipids and phosphatidylserine.
Dependencies are inferred from the claim text.